Previously treated cases tested for RR-/MDR-TB (%) in Mexico
Mexico: Previously treated cases tested for RR-/MDR-TB was 85.0% in 2024. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in Mexico, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Mexico stood at 85.0%. That is the highest value across all 19 years on record.
Compared with earlier readings it is up 25.0% on the previous year and up 16.4% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Mexico peaked at 85.0% in 2024 and was at its lowest, 0.7%, in 2009.
Mexico ranks 100th of 180 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Mexico, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 3.7% | — |
| 2006 | 11.0% | +197.3% |
| 2008 | 28.0% | +154.5% |
| 2009 | 0.7% | -97.4% |
| 2010 | 40.0% | +5455.6% |
| 2011 | 12.0% | -70.0% |
| 2012 | 9.3% | -22.5% |
| 2013 | 12.0% | +29.0% |
| 2014 | 73.0% | +508.3% |
| 2015 | 35.0% | -52.1% |
| 2016 | 24.0% | -31.4% |
| 2017 | 43.0% | +79.2% |
| 2018 | 11.0% | -74.4% |
| 2019 | 16.0% | +45.5% |
| 2020 | 54.0% | +237.5% |
| 2021 | 81.0% | +50.0% |
| 2022 | 60.0% | -25.9% |
| 2023 | 68.0% | +13.3% |
| 2024 | 85.0% | +25.0% |
Mexico compared with similar countries
- Mexico's 85.0% is below the median for upper middle income countries, which is 92.0%, 92% of the median. (52 countries reporting)
- Mexico's 85.0% is above the median for Latin America & Caribbean, which is 85.0%, 1.0× the median. (29 countries reporting)
Biggest year-on-year movements
Years where Previously treated cases tested for RR-/MDR-TB in Mexico changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2010 | +5455.6% | 0.7% | 40.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 10.9% | 0.7% | 28.0% | 4 |
| 2010s | 27.5% | 9.3% | 73.0% | 10 |
| 2020s | 69.6% | 54.0% | 85.0% | 5 |
Countries ranked near Mexico
More health data for Mexico
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6599 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,312 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,760 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate -0.9607 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0377 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.9678 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Mexico?
- Previously treated cases tested for rr-/mdr-tb in Mexico was 85.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Mexico?
- The highest recorded value was 85.0% in 2024.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Mexico?
- The lowest recorded value was 0.7% in 2009.
- How does Mexico rank for previously treated cases tested for rr-/mdr-tb?
- Mexico ranks 100th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Mexico?
- Over the last ten years it is up 16.4%. The long-run trend across the full record is volatile.
- Where does this Mexico data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).